# Artiva Biotherapeutics: Biotechnology, San Diego, United States

> Artiva Biotherapeutics: Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Source: https://millionrounds.com/startup/artiva-biotherapeutics (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# Artiva Biotherapeutics

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Follow Artiva Biotherapeutics and see its new rounds in your feed. [Sign up free](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fartiva-biotherapeutics)

Funding reported Last round: Post-IPO Equity

Biotechnology San Diego, United States

Company summary

- **Founded:** 2019 7 years old
- **Team:** 51 51 to 200 people
- **Funding reported:** $300M in dollars
- **Last round:** Post-IPO Equity date not reported

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Artiva Biotherapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Artiva Biotherapeutics raised

Funding, as reported

Reported in all **$300M** in dollars

Last round **Post-IPO Equity**

Investors listed **5**

SEC Form D **$163M sold, 2 filings, last Apr 2021**

## Founders and team

From the SEC filings it signed: 6 on the team.

- **Esther J. van den Boom** Executive Officer i
- **Fred Aslan** Executive Officer, Director i
- **Jason J. Litten** Executive Officer i
- **Jennifer J. Bush** Executive Officer i
- **Peter J. Flynn** Executive Officer i
- **Thomas J. Farrell** Executive Officer i

On the board, as filed i *Bong J. Koh* *Brian J. Daniels* *Laura J. Stoppel* *Yong-Jun J. Huh* *Yu-Kyeong J. Hwang* *Yvonne J. Yamanaka*

## On a portfolio page

Investors who name them

- [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)

Each firm lists Artiva Biotherapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Biotechnology in United States

Startups like it

- [**Sojournix** Waltham · founded 2016 *Raised*](https://millionrounds.com/company/sojournix)
- [**Receptor Life Sciences** Seattle · founded 2017 *Raised*](https://millionrounds.com/company/receptor-life-sciences)
- [**Attune Pharmaceuticals** New York · founded 2018 *Raised*](https://millionrounds.com/company/attune-pharmaceuticals)
- [**AbbVie** North Chicago · founded 2012](https://millionrounds.com/startup/abbvie-2)
- [**Grail** Menlo Park · founded 2015](https://millionrounds.com/startup/grail-3)
- [**EQRx** Cambridge · founded 2019](https://millionrounds.com/startup/eqrx)
- [**Cerevel Therapeutics** Boston · founded 2018](https://millionrounds.com/startup/cerevel-therapeutics)
- [**Royalty Pharma** New York · founded 1996](https://millionrounds.com/startup/royalty-pharma)

## Is this your company?

Add your raise, your deck and your story, and put Artiva Biotherapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)